Astrophysicists at the University of Colorado's JILA, National Institute of Science and Technology, have conducted an ...
The Cambridge-based biotech's experimental treatment for Duchenne muscular dystrophy hit the mark in a mid-stage study, ...
After proposing the change in the summer of 2023, Celo has migrated to an Ethereum layer-2 protocol built on the OP tech ...
Wave Life Sciences’ experimental treatment for Duchenne muscular dystrophy hit the mark in a mid-stage study, setting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results